Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Oct;40(10):2262–2265. doi: 10.1128/aac.40.10.2262

Pharmacokinetics of a water-soluble fullerene in rats.

P Rajagopalan 1, F Wudl 1, R F Schinazi 1, F D Boudinot 1
PMCID: PMC163515  PMID: 8891126

Abstract

Fullerenes are the recently discovered third allotropic form of carbon. The biological activities of these compounds are being studied for various purposes. The bis(monosuccinimide) derivative of p p'-bis(2-amino-ethyl)-diphenyl-C60 (MSAD-C60) is a water-soluble fullerene derivative. MSAD-C60 has been shown to have antiviral activity against human immunodeficiency virus types 1 and 2 in vitro and to have virucidal and anti-human immunodeficiency virus protease activities. Moreover, MSAD-C60 has been shown to be well tolerated in mice after intraperitoneal administration. The purpose of the present study was to develop a high-performance liquid chromatographic analytical methodology for MSAD-C60 and to characterize the preclinical pharmacokinetics of the compound in rats. Following intravenous administration of the fullerene derivative at a dose of 15 mg/kg of body weight, the concentrations of MSAD-C60 in plasma declined either bi- or triexponentially. The mean terminal-phase half-life of MSAD-C60 was 6.8 +/- 1.1 h (mean +/- standard deviation). Binding studies indicated that the compound is greater than 99% bound to plasma proteins. The average total clearance of the compound was 0.19 +/- 0.06 liter/h/kg. Urine samples obtained 24 h after intravenous administration did not contain detectable levels of the compound, indicating the absence of a significant renal clearance mechanism. The steady-state volume of distribution of MSAD-C60 averaged 2.1 +/- 0.8 liters/kg, indicating that the compound distributes into tissues. At a dose of 15 mg/kg, MSAD-C60 appeared to be well tolerated. However, a dose of 25 mg/kg resulted in shortness of breath and violent movement of the rats, followed by death within 5 min of dosing. Further controlled toxicity studies are needed to fully evaluate the toxicity of the compound.

Full Text

The Full Text of this article is available as a PDF (185.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boxenbaum H. G., Riegelman S., Elashoff R. M. Statistical estimations in pharmacokinetics. J Pharmacokinet Biopharm. 1974 Apr;2(2):123–148. doi: 10.1007/BF01061504. [DOI] [PubMed] [Google Scholar]
  2. Buseck P. R., Tsipursky S. J., Hettich R. Fullerenes from the geological environment. Science. 1992 Jul 10;257(5067):215–217. doi: 10.1126/science.257.5067.215. [DOI] [PubMed] [Google Scholar]
  3. Gerlowski L. E., Jain R. K. Physiologically based pharmacokinetic modeling: principles and applications. J Pharm Sci. 1983 Oct;72(10):1103–1127. doi: 10.1002/jps.2600721003. [DOI] [PubMed] [Google Scholar]
  4. Nelson M. A., Domann F. E., Bowden G. T., Hooser S. B., Fernando Q., Carter D. E. Effects of acute and subchronic exposure of topically applied fullerene extracts on the mouse skin. Toxicol Ind Health. 1993 Jul-Aug;9(4):623–630. doi: 10.1177/074823379300900405. [DOI] [PubMed] [Google Scholar]
  5. Rocci M. L., Jr, Jusko W. J. LAGRAN program for area and moments in pharmacokinetic analysis. Comput Programs Biomed. 1983 Jun;16(3):203–216. doi: 10.1016/0010-468x(83)90082-x. [DOI] [PubMed] [Google Scholar]
  6. Schinazi R. F., Sijbesma R., Srdanov G., Hill C. L., Wudl F. Synthesis and virucidal activity of a water-soluble, configurationally stable, derivatized C60 fullerene. Antimicrob Agents Chemother. 1993 Aug;37(8):1707–1710. doi: 10.1128/aac.37.8.1707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Toniolo C., Bianco A., Maggini M., Scorrano G., Prato M., Marastoni M., Tomatis R., Spisani S., Palú G., Blair E. D. A bioactive fullerene peptide. J Med Chem. 1994 Dec 23;37(26):4558–4562. doi: 10.1021/jm00052a015. [DOI] [PubMed] [Google Scholar]
  8. Tsuchiya T., Yamakoshi Y. N., Miyata N. A novel promoting action of fullerene C60 on the chondrogenesis in rat embryonic limb bud cell culture system. Biochem Biophys Res Commun. 1995 Jan 26;206(3):885–894. doi: 10.1006/bbrc.1995.1126. [DOI] [PubMed] [Google Scholar]
  9. Veng-Pedersen P. Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part I). Clin Pharmacokinet. 1989 Nov;17(5):345–366. doi: 10.2165/00003088-198917050-00004. [DOI] [PubMed] [Google Scholar]
  10. Yamago S., Tokuyama H., Nakamura E., Kikuchi K., Kananishi S., Sueki K., Nakahara H., Enomoto S., Ambe F. In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity. Chem Biol. 1995 Jun;2(6):385–389. doi: 10.1016/1074-5521(95)90219-8. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES